Pardes Biosciences Inc PRDS.O :
* PARDES BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* Q1 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA
* CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF
MARCH
31, 2023, WERE $172.2 MILLION
* AS OF APRIL 30, 2023, PARDES' PRELIMINARY CASH, CASH
EQUIVALENTS
AND SHORT-TERM INVESTMENTS TOTALED APPROXIMATELY $168.2 MILLION
* PARDES BIOSCIENCES- EXPECTS CASH, CASH EQUIVALENTS ON HAND
AS OF
MARCH 31, 2023, WILL BE SUFFICIENT TO FUND CURRENT PLANNED
OPERATIONS FOR NEXT 12 MONTHS
Source text for Eikon: ID:nGNX8FSJSR
Further company coverage: PRDS.O